Position in CELC
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$13,588,138
+$9,460,882 QoQ
Shares Held
119,048
-62.0% QoQ
Ownership
0.244%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
5 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in CELC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026FEDERATED HERMES, INC. holds $2,357,893,949 across 146 Biotechnology names. CELC ranks #39 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
687,816 | $227,577,679 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
254,946 | $196,981,475 | |
| 3 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,286,303 | $111,869,771 | |
| 4 | MRNA |
Moderna, Inc.
|
1,977,079 | $100,435,613 | |
| 5 | IDYA |
IDEAYA Biosciences, Inc.
|
2,987,107 | $99,530,405 | |
| 6 | INSM |
INSMED Inc
|
538,257 | $88,015,784 | |
| 7 | CNTA |
Centessa Pharmaceuticals plc
|
2,049,439 | $81,403,717 | |
| 8 | EYPT |
EyePoint, Inc.
|
5,669,589 | $73,081,000 |
All Filings in CELC
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $13,588,138 | 119,048 | Shares | Defined | 2026-05-11 | |
| 2021-12-31 | $4,127,256 | 312,908 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $5,632,344 | 312,908 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $7,509,792 | 312,908 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $3,959,144 | 276,091 | Shares | Defined | 2021-05-13 | |
| No filing history on record for this holder in this stock. | ||||||